91 related articles for article (PubMed ID: 23781664)
1. Risk factors for mortality in a south Indian population on generic antiretroviral therapy.
Rupali P; Mannam S; Bella A; John L; Rajkumar S; Clarence P; Pulimood SA; Samuel P; Karthik R; Abraham OC; Mathai D
J Assoc Physicians India; 2012 Dec; 60():11-4. PubMed ID: 23781664
[TBL] [Abstract][Full Text] [Related]
2. Two-year treatment outcomes of patients enrolled in India's national first-line antiretroviral therapy programme.
Bachani D; Garg R; Rewari BB; Hegg L; Rajasekaran S; Deshpande A; Emmanuel KV; Chan P; Rao KS
Natl Med J India; 2010; 23(1):7-12. PubMed ID: 20839585
[TBL] [Abstract][Full Text] [Related]
3. API consensus guidelines for use of antiretroviral therapy in adults (API-ART guidelines). Endorsed by the AIDS Society of India.
Gupta SB; Pujari SN; Joshi SR; Patel AK;
J Assoc Physicians India; 2006 Jan; 54():57-74. PubMed ID: 16649742
[TBL] [Abstract][Full Text] [Related]
4. Impact of generic antiretroviral therapy (ART) and free ART programs on time to initiation of ART at a tertiary HIV care center in Chennai, India.
Solomon SS; Lucas GM; Kumarasamy N; Yepthomi T; Balakrishnan P; Ganesh AK; Anand S; Moore RD; Solomon S; Mehta SH
AIDS Care; 2013 Aug; 25(8):931-6. PubMed ID: 23216257
[TBL] [Abstract][Full Text] [Related]
5. Short-term risk of AIDS or death in people infected with HIV-1 before antiretroviral therapy in South Africa: a longitudinal study.
Badri M; Lawn SD; Wood R
Lancet; 2006 Oct; 368(9543):1254-9. PubMed ID: 17027731
[TBL] [Abstract][Full Text] [Related]
6. Eosinophilic folliculitis: before and after the introduction of antiretroviral therapy.
Rajendran PM; Dolev JC; Heaphy MR; Maurer T
Arch Dermatol; 2005 Oct; 141(10):1227-31. PubMed ID: 16230559
[TBL] [Abstract][Full Text] [Related]
7. Risk of cancers during interrupted antiretroviral therapy in the SMART study.
Silverberg MJ; Neuhaus J; Bower M; Gey D; Hatzakis A; Henry K; Hidalgo J; Lourtau L; Neaton JD; Tambussi G; Abrams DI
AIDS; 2007 Sep; 21(14):1957-63. PubMed ID: 17721103
[TBL] [Abstract][Full Text] [Related]
8. Immune reconstitution inflammatory syndrome of tuberculosis among HIV-infected patients receiving antituberculous and antiretroviral therapy.
Manosuthi W; Kiertiburanakul S; Phoorisri T; Sungkanuparph S
J Infect; 2006 Dec; 53(6):357-63. PubMed ID: 16487593
[TBL] [Abstract][Full Text] [Related]
9. Interruption of combination antiretroviral therapy and risk of clinical disease progression to AIDS or death.
Holkmann Olsen C; Mocroft A; Kirk O; Vella S; Blaxhult A; Clumeck N; Fisher M; Katlama C; Phillips AN; Lundgren JD;
HIV Med; 2007 Mar; 8(2):96-104. PubMed ID: 17352766
[TBL] [Abstract][Full Text] [Related]
10. Evidence for extended age dependent maternal immunity in infected children: mother to child transmission of HIV infection and potential interventions including sulfatides of the human fetal adnexa and complementary or alternative medicines.
Bhargav H; Huilgol V; Metri K; Sundell IB; Tripathi S; Ramagouda N; Jadhav M; Raghuram N; Ramarao NH; Koka PS
J Stem Cells; 2012; 7(3):127-53. PubMed ID: 23619381
[TBL] [Abstract][Full Text] [Related]
11. Antiretroviral therapy in AIDS patients with CMV disease: impact on the survival and long-term treatment outcome.
Sungkanuparph S; Chakriyanuyok T; Butthum B
J Infect; 2008 Jan; 56(1):40-3. PubMed ID: 18037166
[TBL] [Abstract][Full Text] [Related]
12. Interruption of antiretroviral treatment in HIV-infected patients with preserved immune function is associated with a low rate of clinical progression: a prospective study by AIDS Clinical Trials Group 5170.
Skiest DJ; Su Z; Havlir DV; Robertson KR; Coombs RW; Cain P; Peterson T; Krambrink A; Jahed N; McMahon D; Margolis DM;
J Infect Dis; 2007 May; 195(10):1426-36. PubMed ID: 17436222
[TBL] [Abstract][Full Text] [Related]
13. Antiretroviral therapy in a thousand patients with AIDS in Haiti.
Severe P; Leger P; Charles M; Noel F; Bonhomme G; Bois G; George E; Kenel-Pierre S; Wright PF; Gulick R; Johnson WD; Pape JW; Fitzgerald DW
N Engl J Med; 2005 Dec; 353(22):2325-34. PubMed ID: 16319381
[TBL] [Abstract][Full Text] [Related]
14. Earlier initiation of antiretroviral therapy, increased tuberculosis case finding and reduced mortality in a setting of improved HIV care: a retrospective cohort study.
Hermans SM; van Leth F; Manabe YC; Hoepelman AI; Lange JM; Kambugu A
HIV Med; 2012 Jul; 13(6):337-44. PubMed ID: 22296211
[TBL] [Abstract][Full Text] [Related]
15. Baseline CD4 cell counts and outcomes among adult treatment naive HIV patients after taking fixed dose combination GPO-VIR-S and GPO-VIR-Z in Thailand.
Kyaw NL; Thanachartwet V; Kiertiburanakul S; Desakorn V; Chamnanchanunt S; Chierakul W; Manosuthi W; Pitisuttithum P; Sungkanuparph S
Southeast Asian J Trop Med Public Health; 2013 Mar; 44(2):232-43. PubMed ID: 23691633
[TBL] [Abstract][Full Text] [Related]
16. Response to highly active antiretroviral therapy among severely immuno-compromised HIV-infected patients in Cambodia.
Madec Y; Laureillard D; Pinoges L; Fernandez M; Prak N; Ngeth C; Moeung S; Song S; Balkan S; Ferradini L; Quillet C; Fontanet A
AIDS; 2007 Jan; 21(3):351-9. PubMed ID: 17255742
[TBL] [Abstract][Full Text] [Related]
17. [Clinical characteristics of highly active antiretroviral therapy-associated immune reconstruction inflammation in acquired immunodeficiency syndrome].
Liu M; Zheng YH; Zhou GQ; Zhou HY; Chen Z; He Y; Chen X; Zheng LW; Jia L; He M
Zhonghua Yi Xue Za Zhi; 2011 Feb; 91(5):304-8. PubMed ID: 21419003
[TBL] [Abstract][Full Text] [Related]
18. Determinants of mortality and nondeath losses from an antiretroviral treatment service in South Africa: implications for program evaluation.
Lawn SD; Myer L; Harling G; Orrell C; Bekker LG; Wood R
Clin Infect Dis; 2006 Sep; 43(6):770-6. PubMed ID: 16912954
[TBL] [Abstract][Full Text] [Related]
19. High incidence of zidovudine induced anaemia in HIV infected patients in eastern India.
Agarwal D; Chakravarty J; Chaube L; Rai M; Agrawal NR; Sundar S
Indian J Med Res; 2010 Oct; 132():386-9. PubMed ID: 20966515
[TBL] [Abstract][Full Text] [Related]
20. A prospective study of highly active antiretroviral therapy in Indian human immunodeficiency virus positive patients.
Rajesh R; Vidyasagar S; Varma DM; Naik A; Hegde BM; Guddattu V; Kamath A
Int J Risk Saf Med; 2013 Jan; 25(1):53-65. PubMed ID: 23442298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
